In another study, HPV 18 E7 specific CD4+ T cell responses were evaluated before treatment in patients with CIN or low-grade invasive cervical cancer, and in age-matched healthy controls (102). This evidence concerns the gene CD4 and cervical squamous intraepithelial neoplasia.